Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A gentle buzz on the ears may sharpen balance — a trial puts it to the test

NCT ID NCT07730398

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests whether a mild electrical current applied behind the ears can improve how healthy adults sense and control their balance. Each participant will try two types of stimulation (low-frequency and high-frequency) as well as a no-stimulation session. Researchers will measure how accurately they detect motion, track movement, and correct for disturbances.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
noisy galvanic vestibular stimulation (nGVS) delivered through electrodes on the mastoid bones
What this could lead to
If it works, this could point toward a non-invasive way to enhance balance and spatial awareness in healthy people or astronauts.
What could go wrong
This is a small, early-stage trial in only 18 healthy adults. The effects may be subtle or not translate to real-world performance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

18 people

The number who actually took part.

Started

Feb 2024

Finished

Mar 2024

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects were required to pass a physical exam adminisitrated by NASA JSC Clinic. Exclusion Criteria: * No history of neurologic, vestibular, or autonomic disease.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sensorimotor performance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nasa Jsc B21

    Houston, Texas, 77058, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.